BACK
GLOBAL EXECUTIVE MOVES

April 2021
Catamaran Bio Announces Appointment of Scott Holmes as Chief Financial Officer
Catamaran Bio announced the appointment of Scott Holmes, MS, MBA, as Chief Financial Officer.
Catamaran Bio is a privately held biotechnology company based in Cambridge, MA employing approximately 50 people. Its mission is to harness the power of its proprietary TAILWIND

Platform to develop safe and effective, off-the-shelf, allogeneic immune cell therapies for the treatment of patients with cancer and immune disorders.